货号:A240639 同义名: Win35833;WIN 35,833
Ciprofibrate is an agonist of peroxisome proliferator-activated receptor PPAR⍺. It is used in dyslipidaemia.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | PPARα ↓ ↑ | PPARβ/δ ↓ ↑ | PPARγ ↓ ↑ | PPARδ ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fenofibric acid | ✔ | 98% | |||||||||||||||||
GW6471 |
++
PPARα, IC50: 0.24 μM |
99%+ | |||||||||||||||||
GSK3787 |
++
PPARδ, pIC50: 6.6 |
++
PPARδ, pIC50: 6.6 |
99%+ | ||||||||||||||||
FH535 | ✔ | 98%+ | |||||||||||||||||
GW9662 |
+++
PPARα, IC50: 32 nM |
+++
PPARγ, IC50: 3.3 nM |
98% | ||||||||||||||||
T0070907 |
++++
PPARγ, IC50: 1 nM |
98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | Ciprofibrate is a potent peroxisome proliferator and increases the phosphorylation level of the PPARalpha. Ciprofibrate (500 μM; 4 hours) increases the PPARa phosphorylation level in rat Fao cells[3]. In a LucLite assay, Ciprofibrate (10-100μM; 24 hours) induces PPARR activation by existing increased LUC activities in the rat liver H4IIEC3 cells transfected with PPRE-AB LUC reporter gene plasmid[4]. A single dose of ciprofibrate (5 mg/kg by gastric intubation) significantly induces rat liver bilirubin conjugation as well as UGT1A1, UGT1A5 and PPARαexpression[5]. The main effects of ciprofibrate on G cells are mediated from the antrum lumen, and the mechanism is dependent on PPAR-alpha[6]. Ciprofibrate inhibited cigarette smoke extract-induced rat ASM cell contraction and proliferation in vitro. Ciprofibrate improved pulmonary function, inhibited airway hypercontraction, and ameliorated morphological small airway remodeling, including airway smooth muscle proliferation, in CS-exposed rats. Ciprofibrate also significantly reduced IL-1β, IL-12p70, IL-17A and IL-18 expression, which are related to airway remodeling, in the sera of CS-exposed rats[7]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT03031821 | Prostate Cancer ... 展开 >> Metabolic Syndrome 收起 << | Phase 3 | Not yet recruiting | June 1, 2023 | Canada, British Columbia ... 展开 >> BC Cancer Agency - Vancouver Cancer Centre Not yet recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Bernie Eigl, MD 604-877-6000 bernie.eigl@bccancer.bc.ca Principal Investigator: Bernie Eigl, MD 收起 << |
NCT01480687 | Hypertension ... 展开 >>Hypertriglyceridemia 收起 << | Phase 4 | Unknown | December 2012 | Brazil ... 展开 >> Hospital Universitario Pedro Ernesto Recruiting Rio de Janeiro, RJ, Rio de Janeiro, Brazil Contact: Marcela A Casanova, MSc 55-21-2868-8484 cela.abreu@gmail.com 收起 << |
NCT00350038 | Hypertension ... 展开 >>Dyslipidemia 收起 << | Phase 4 | Completed | - | Hungary ... 展开 >> Sanofi-aventis Budapest, Hungary 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.46mL 0.69mL 0.35mL |
17.29mL 3.46mL 1.73mL |
34.58mL 6.92mL 3.46mL |
CAS号 | 52214-84-3 |
分子式 | C13H14Cl2O3 |
分子量 | 289.15 |
别名 | Win35833;WIN 35,833;CCRIS 173;BRN 1984981;(±)-Ciprofibrate |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,2-8°C |
溶解度 |
DMSO: 105 mg/mL(363.13 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |